Search Results - Gordon MacGregor

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del

    Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del by Andrea Lopez, Conor Daly, G. Vega-Hernández, Gordon MacGregor, Jaime Rubin

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis

    Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis by J.S. Elborn, Alex Horsley, Gordon MacGregor, Diana Bilton, Ralph Grosswald, Sanjeev Ahuja, EB Springman

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases

    Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases by Robert D. Gray, Gordon MacGregor, Donald Noble, M. Imrie, Maria H Dewar, A. Christopher Boyd, J. Alastair Innes, David J. Porteous, A P Greening

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis

    LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdo... by G. Vega-Hernández, Gordon MacGregor, Andrew Wilfin, Francis Adams, Connor J. Haugh, Carl A. Baxter, Heike Wöhling, Siân Clarke, Susan C. Charman, S.B. Carr

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease

    A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease by M. Pritchard, Lydia C. Powell, Georgina Menzies, Paul D. Lewis, Karl Hawkins, Chris J. Wright, Iolo Doull, Timothy R. Walsh, E. Onsøyen, A. Dessen, Rolf Myrvold, Philip D. Rye, Astrid Hilde Myrset, Howard N.E. Stevens, Lee Ann Hodges, Gordon MacGregor, J. B. Neilly, Katja E. Hill, David W. Thomas

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Stepwise pathogenic evolution of <i>Mycobacterium abscessus</i>

    Stepwise pathogenic evolution of <i>Mycobacterium abscessus</i> by Josephine M. Bryant, Karen Brown, Sophie Burbaud, Isobel Everall, Juan M. Belardinelli, Daniela Rodriguez-Rincon, Dorothy Grogono, Chelsea Peterson, Deepshikha Verma, Ieuan Evans, Christopher Ruis, Aaron Weimann, Divya Arora, Sony Malhotra, Bridget P. Bannerman, Charlotte Passemar, Kerra Templeton, Gordon MacGregor, Kasim Jiwa, Andrew J. Fisher, Tom L. Blundell, Diane Ordway, Mary Jackson, Julian Parkhill, R. Andres Floto

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial

    Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentr... by Sivagurunathan Sutharsan, Edward F. McKone, D.G. Downey, J. Duckers, Gordon MacGregor, Elizabeth Tullis, Eva Van Braeckel, Claire Wainwright, Danie Watson, Neil Ahluwalia, Bote G. Bruinsma, Christopher Harris, Anna P. Lam, Yiyue Lou, Samuel M. Moskowitz, Simon Tian, Jason X.‐J. Yuan, David Waltz, Marcus Mall, Paul Aurora, Stijn Verhulst, Danie Watson, Michael Lorenz, Jobst Roehmel, Wolfgang Gleiber, Susanne Naehrig, Florian Stehling, Sivagurunathan Sutharsan, Silke van Koningsbruggen‐Rietschel, Rainald Fischer, D.G. Downey, Charles Haworth, J. Duckers, Julian Legg, Peter Barry, Rebecca Thursfield, Simon Doe, Tom Hilliard, Gordon MacGregor, E.F. Nash, Nicholas Withers, D. Peckham, Helen Louise Barr, Timothy Lee, Robert D. Gray, F. Vermeulen, Eva Van Braeckel, Eef Vanderhelst, Philip Robinson, Claire Wainwright, Daniel J. Smith, Siobhain Mulrennan, Barry Clements, Peter Wark

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

    Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials by Ahmet Uluer, Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall, Edward F. McKone, Bonnie W. Ramsey, Steven M. Rowe, Ronald C. Rubenstein, Jennifer L. Taylor‐Cousar, Elizabeth Tullis, Lael M. Yonker, Chenghao Chu, Anna P. Lam, Nitin Nair, Patrick R. Sosnay, Simon Tian, Fredrick Van Goor, Lakshmi Viswanathan, David Waltz, Linda T. Wang, Yingmei Xi, Joanne Billings, Alex Horsley, Alex Horsley, E.F. Nash, Marleen Bakker, Eva Van Braeckel, Petrus Merkus, Christof J. Majoor, Karen McCoy, Joanne Billings, Krishna Pancham, James Tolle, Bryon Quick, Ahmet Uluer, Emily DiMango, A. Vijaya Rao, Santiago Reyes, Ross C. Klingsberg, Celeste Barreto, Victor E. Ortega, Donna Beth Willey‐Courand, C. Schwarz, Sivagurunathan Sutharsan, Rainald Fischer, Jane C. Davies, J. Duckers, Alex Horsley, Simon Doe, E.F. Nash, Marleen Bakker, Harry Heijerman, Eva Van Braeckel, Petrus Merkus, Christof J. Majoor, George M. Solomon, Christian A. Merlo, Jennifer Griffonnet, Joseph M. Pilewski, Jordan Dunitz, Saba Sheikh, Ronald C. Rubenstein, Daniel Rosenbluth, Theodore G. Liou, M.V. Indihar, Krishna Pancham, Lael M. Yonker, Samya Z. Nasr, Jennifer Griffonnet, Cynthia Brown, Gregory S. Sawicki, Jennifer Ruddy, Emily DiMango, Bryan Garcia, Andrew T. Braun, Alex H. Gifford, Nighat Mehdi, Maria Tupayachi Ortiz, Raksha Jain, Francisco J. Calimano, Jimmy Johannes, Cori Daines, Jason Fullmer, Joel Mermis, Christopher Barrios, Ngoc P. Ly, Brian Casserly, Stephan Eisenmann, Helge Hebestreit, Alexander Kiefer, Sivagurunathan Sutharsan, Rainald Fischer, Gordon MacGregor, D. Peckham, M.J. Ledson, Eva Van Braeckel, Petrus Merkus, Noel G. McElvaney

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

    Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium by Josephine M. Bryant, Dorothy Grogono, Daniela Rodriguez-Rincon, Isobel Everall, Karen Brown, Pablo Moreno, Deepshikha Verma, Emily Hill, Judith Drijkoningen, Peter H. Gilligan, Charles R. Esther, Peadar G. Noone, Olivia Giddings, Scott C. Bell, Rachel Thomson, Claire Wainwright, Chris Coulter, Sushil Pandey, Michelle Wood, Rebecca E. Stockwell, Kay A. Ramsay, L. Sherrard, Timothy J. Kidd, Nassib Jabbour, Graham Johnson, Luke D. Knibbs, Lídia Morawska, Peter D. Sly, Andrew Jones, Diana Bilton, Ian F. Laurenson, Michael Ruddy, Stephen Bourke, I.C.J.W. Bowler, S. Jonathan Chapman, Andrew Clayton, M. Cullen, Owen Dempsey, Miles Denton, Maya Desai, Richard J. Drew, F. Edenborough, J. C. Evans, Jonathan Folb, T. Daniels, Helen Humphrey, B. Isalska, Søren Jensen‐Fangel, Bodil Jönsson, Andrew Jones, Terese L. Katzenstein, Troels Lillebæk, Gordon MacGregor, Sarah Mayell, Michael Millar, Deborah Modha, E.F. Nash, Christopher J. O’Brien, Deirdre O’Brien, Chandra Ohri, C. Pao, D. Peckham, Felicity Perrin, Audrey Perry, T. Pressler, Laura Prtak, Tavs Qvist, A. Robb, Helen Rodgers, Kirsten Schaffer, Nadia Shafi, Jakko van Ingen, Martin Walshaw, Danie Watson, N. West, J.L. Whitehouse, Charles Haworth, Simon R. Harris, Diane Ordway, Julian Parkhill, R. Andres Floto

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

    Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis by Diana Bilton, Tacjana Pressler, Isabelle Fajac, John P. Clancy, Dorota Sands, Predrag Minić, Marco Cipolli, Ivanka Galeva, Amparó Solé, Alexandra L. Quittner, Keith Liu, John P. McGinnis, Gina Eagle, Renu Gupta, Michael W. Konstan, Sabine Renner, Christiane Knoop, Anne Malfroot, Lieven Dupont, Kristine Desager, Frans De Baets, Miroslava Bosheva, V. Nedkova, Ivan Galabov, Ivanka Galeva, Andreas Freitag, Nancy Morrison, Pearce Wilcox, T. Pressler, Yves Martinet, R. Chiron, Isabelle Fajac, Stephan Dominique, Philippe Reix, Anne Prévötat, Isabelle Sermet‐Gaudelus, I. Durieu, Rainald Fischer, Rudolf M. Huber, Doris Staab, Uwe Mellies, Wolfgang Sextro, Tobias Welte, Heinrike Wilkens, Urte Sommerwerk, Burkhard Bewig, I. Inglezos, Stavros‐Eleftherios Doudounakis, Olga Bede, Ferenc Gönczi, Rita Újhelyi, Edward F. McKone, Paul McNally, V. Lucidi, Marco Cipolli, Mario La Rosa, L. Minicucci, Rita Padoan, Giovanna Pisi, R. Gagliardini, Carla Colombo, Inez Bronsveld, Ewa Sapiejka, Henryk Mazurek, Dorota Sands, G Górnicka, Iwona Stelmach, Halina Batura‐Gabryel, Marta Rachel, Predrag Minić, Jaroslava Orosova, B. Takáč, A. Feketova, Carmen Montero Martínez, Gloria Garcia Hernandez, José Ramón Villa-Asensi, Silvia Gärtner, Amparó Solé, Anders Lindblad, M.J. Ledson, Diana Bilton, J.L. Whitehouse, Alan R Smyth, I. Ketchell, Timothy Lee, Gordon MacGregor

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: